You may have heard about mpox. After making it through more than three years of COVID, plus last year’s mpox wave, it makes sense to feel uneasy. Especially, when we are seeing it spread among the LGBTQ+ community. But we’re smarter now. We’ve learned about how diseases spread, and we’re prepared to do what it takes to stay safe. We’re learning all we can, and we’re gonna keep you updated about what we’ve learned. Here’s what we know so far:
For a complete guide on how to prepare for mpox spread this summer, click here.
During August–October 2022, CDC provided clinical consultation for 57 hospitalized patients with severe manifestations of mpox, most of whom were Black men with AIDS. Delays were observed in initiation of mpox-directed therapies. Twelve patients died, and mpox was a cause of death or contributing factor in five patients to date, with several other deaths still under investigation.
Clinicians should consider early treatment with available therapeutics for those at risk for severe mpox disease, particularly patients with AIDS. Engaging all persons with HIV in care remains a critical public health priority.
Read the report from the CDC here.